Peptides: What They Are, How They Work, and the Hidden Risks

Peptides have become the hottest topic in the biohacking and longevity space. Podcasters, influencers, and private clinics present them as the new frontier of anti-aging, muscle regeneration, and weight loss. But between the marketing promises and scientific reality lies an enormous gap that deserves careful attention.

This guide explains what peptides really are, how they work in the body, what the concrete risks are, and what science actually says — no hype and no censorship.

What are peptides, in simple terms

A peptide is a short chain of amino acids, the fundamental building blocks of proteins. If proteins are full sentences, peptides are individual words: smaller structures, but capable of transmitting very precise biological messages.

Your body naturally produces thousands of them. Insulin, for example, is a peptide. Collagen gets broken down into peptides during digestion. Even glutathione, the body's main cellular antioxidant, is a tripeptide (three amino acids linked together).

What makes peptides interesting for medicine and biohacking is their ability to act as signals: they bind to specific receptors on cells and trigger targeted biological responses. Unlike traditional drugs, which often have broad "carpet-bombing" effects, peptides can be designed to hit very specific targets.

How they work in the body

Peptides operate like keys that open molecular locks. When a peptide encounters the right receptor on a cell's surface, it triggers a cascade of events: it can stimulate growth hormone production, accelerate tissue repair, modulate the immune system, or reduce inflammation.

This is why the field has exploded. The specificity of peptides makes them potentially very precise tools. But "potentially" is the key word. Most research is still in preclinical stages, conducted on animals or in vitro.

Synthetic peptides used in biohacking are administered almost exclusively via subcutaneous injection. The reason is simple: being chains of amino acids, most would be digested and broken down in the stomach before reaching the bloodstream. Some exceptions exist (BPC-157, for example, is stable in gastric acid), but injection remains the standard route.

The peptide boom: why now

The global peptide therapeutics market reached $52.6 billion in 2025. Growth has been driven by three main factors.

First is the explosive success of GLP-1 drugs like semaglutide and tirzepatide for weight loss. These drugs are technically peptides, and their media impact brought millions of people to discover the world of peptides for the first time.

Second is biohacking culture, which has shifted attention from reactive medicine to preventive and optimization-focused approaches. Figures like Bryan Johnson and Andrew Huberman have helped normalize the idea of "hacking" one's own biology.

Third — and less noble — is the enormous unregulated market that developed online. Peptides sold as "research chemicals," purchasable without prescription, often from Chinese labs with minimal or nonexistent quality controls.

The real risks: what nobody tells you

This is where the conversation gets serious. The hype around peptides has obscured very real risks that anyone considering their use needs to understand.

The quality crisis. Independent testing has revealed alarming data about the unregulated market. 20% of analyzed products were contaminated or mislabeled. 30% contained the wrong molecule entirely. 65% of injectable preparations exceeded safety thresholds for endotoxins. We are not talking about "slight inaccuracies," but concentration variability of up to 20 times the labeled dose.

What does this mean in practice? It means that anyone injecting a peptide purchased online could be taking a radically different dose than expected, or a completely different molecule, or a product contaminated with bacteria. Documented cases include injection site abscesses, sepsis, and hospital admissions.

The lack of human data. Most of the popular peptides are supported almost exclusively by animal studies. Hundreds of papers on rats and mice, but very few clinical trials on humans. This does not mean they don't work, but it means we don't know with certainty what safe dosages, long-term effects, and interactions look like.

The theoretical cancer risk. Some peptides stimulate angiogenesis — the formation of new blood vessels. This is positive for healing, but potentially dangerous if undiagnosed cancer cells exist in the body: new vessels could feed tumor growth. This is a theoretical risk, not proven in humans, but one the scientific community takes seriously.

What the regulations say

In Europe, the situation is more restrictive than in the United States. The EMA (European Medicines Agency) approves peptides as drugs only after rigorous clinical trials. Peptides like semaglutide and tirzepatide are approved and prescribable.

The US FDA has adopted an increasingly hard line since 2024, banning compounding of BPC-157, TB-500, and 15 other peptides, issuing warning letters to hundreds of companies, and conducting warehouse raids on distributors.

In Italy and most of Europe, unapproved peptides fall into a gray area. Purchasing them "for research" isn't technically illegal, but their use on humans is not authorized, and no doctor can legally prescribe them outside of experimental protocols or approved pharmaceuticals.

How to navigate: a rational compass

If you're interested in peptides, here's a framework to navigate the field without being manipulated.

First rule: distinguish between approved and unapproved peptides. Semaglutide and insulin are peptides with decades of clinical data. BPC-157 and TB-500 are not. Lumping them together is intellectually dishonest.

Second rule: distrust anecdotal testimonials. Confirmation bias is powerful. Someone who pays hundreds of euros for a peptide is psychologically incentivized to believe it works. Only controlled, randomized studies can establish a causal link.

Third rule: source quality matters more than the molecule. If you decide to experiment anyway (at your own risk), demand certificates of analysis from independent third-party labs, not from the vendor themselves. It's the only form of minimal guarantee.

Fourth rule: optimize the basics first. Most people searching for miracle peptides haven't yet optimized sleep, nutrition, exercise, and stress management. These four levers — free and scientifically solid — are worth more than any peptide.

The bottom line

Peptides represent a fascinating and promising field of research. Some approved molecules are already changing millions of lives. But the gap between serious research and the consumer market is enormous and dangerous.

The smartest attitude is informed curiosity: follow the research, wait for clinical data, and don't let marketing urgency capture you. Your body is not a laboratory for uncontrolled experiments.